Hybrid imaging, a cutting-edge technique in cancer research, combines two or more imaging modalities to provide comprehensive information about tumor biology, morphology, and function. Typically, it merges anatomical imaging, like CT or MRI, with functional imaging such as PET or SPECT. This synergy enables more accurate tumor localization, characterization, and staging, crucial for treatment planning and monitoring. For instance, PET/CT combines positron emission tomography (PET) for detecting metabolic activity with computed tomography (CT) for precise anatomical localization, offering a holistic view of cancer progression. Similarly, PET/MRI pairs PET's functional data with MRI's superior soft tissue contrast, enhancing the understanding of tumor behavior. Hybrid imaging holds promise for personalized cancer management, facilitating early detection, treatment optimization, and assessing therapeutic response, ultimately improving patient outcomes.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States